Pfizer, BioNTech challenge Moderna’s COVID vaccine patent win in U.K.

9 hours ago 2
Covid-19 Vaccine

carmengabriela

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to London's Court of Appeal on Thursday seeking to overturn a prior court ruling that granted a patent win for their rival Moderna (NASDAQ:MRNA).

The

Recommended For You

More Trending News

Read Entire Article